9,10-Bis[N-(2-naphthyl)anilino]anthracene>98.0%(HPLC)(N)200mg

3-Acetyl-4,6-dimethyl-1,2-dihydropyridin-2-one, 95.0%, 250mg

2-Amino-5-phenylpentanoic acid, 95.0%, 250mg

tert-Butyl 8-oxo-5-oxa-2-azaspiro[3.4]octane-2-carboxylate, 97%, 1g

6-Methoxy-3-nitro-2-(trifluoromethyl)pyridine, 95+%, 100mg

8-aminoquinoline-2-carboxylic acid, 95.0%, 250mg

4,4',4'',4'''-(Pyrene-1,3,6,8-tetrayl)tetrabenzaldehyde, 95%, 1g

2-Chloro-6-nitropyridine, 97.0%, 5g

3,3-dimethyl-2-pyrrolidinone, 95.0%, 250mg

1-Ethyl-3-methyl-1H-imidazol-3-ium hexafluorophosphate(V), 97%, 5g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(thiazol-4-yl)propanoic acid, 97.0%, 10g

1,2,3,4-Tetrahydropyrido[2,3-b]pyrazine, 95.0%, 1g

Phase contrast Abbe condenser with slide for Plan PLPHi S40 phase contrast infinity corrected objectives, slide with 40x phasing, telescope and green filter